New class action for Freeport-McMoRan Inc. (FCX) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 1/12/2026.

NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities and sellers of put options of Sprouts Farmers Market, Inc. (NASDAQ: SFM) between June 4, 2025 and October 29, 2025, both dates inclusive (the “Class Period”), of the important January 26, 2026 lead plaintiff deadline.

New class action for Quantum Biopharma Ltd (QNTM) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/23/2026

New class action for Firefly Aerospace Inc. (FLY) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 1/12/2026

SAN FRANCISCO, Dec. 25, 2025 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Telix Pharmaceuticals Ltd. (NASDAQ: TLX) that the deadline to move the Court for appointment as lead plaintiff in the pending securities class action lawsuit is January 9, 2026.

New class action for Skye Bioscience, Inc. (SKYE) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 1/16/2026

The nostalgic Total 90 product line is central to Nike's World Cup plans. It just never renewed the trademark rights.

Microsoft Corp. NASDAQ: MSFT stock is up more than 15% in 2025. Even after the latest slide in technology stocks, the stock is still up about 3% in the last month.

PG&E Corp. is repositioning for consistent EPS growth and strong shareholder returns, despite a legacy of wildfire-related challenges. PCG trades at a low ~10.5x P/E, targets 9%+ annual EPS growth, and plans a 20% dividend payout ratio by 2028. Massive $73 billion capital deployment through 2030 will expand the rate base, with no new equity issuance and a focus on grid modernization and renewables.

With the markets showing signs of rotating away from tech, high-yield dividend stocks are worth another look. ETFs focused on international dividend-paying stocks look particularly attractive at the moment.

NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the “Class Period”), of the important January 16, 2026 lead plaintiff deadline.

Hudbay Minerals remains a buy as copper prices surge, supporting robust forward earnings and manageable valuation multiples. Despite Q3 operational headwinds at key sites, HBM delivered strong YTD margin expansion and significant net income growth. HBM's balance sheet is improving, with debt reduction underway and a price/book and forward P/E still at or below sector medians.

NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gauzy Ltd. (NASDAQ: GAUZ) between March 11, 2025 and November 13, 2025, both dates inclusive (the “Class Period”), of the important February 6, 2026 lead plaintiff deadline .

WTI crude oil tests the 50-day average as futures traders weigh real buying, Oil Demand signals, and resistance levels in a cautious Oil Outlook.

After losing some value lately, a hammer chart pattern has been formed for Cimpress (CMPR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

The consensus price target hints at a 25.6% upside potential for SEI (SEIC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Wyndham Hotels & Resorts (WH) shares have underperformed in 2025, delivering a -20% total return versus the S&P 500's +17%. WH faced a challenging U.S. hotel market, prompting a downward revision of FY 2025 RevPAR guidance to -2% to -3%. Despite near-term headwinds, I believe WH's long-term growth prospects remain strong and its valuation is highly attractive.

Faced with excess supply that is likely to carry over into the new year, crude oil prices are likely to continue to struggle in 2026. The U.S. Energy Information Administration (EIA) expects the supply glut to persist through 2026, which should, in turn, put downward pressure on oil prices—crude oil could fall to $55 per barrel on average for the first quarter.

Centerra Gold Inc. (CGAU) is upgraded to Buy (from prior Hold rating), reflecting strong leverage to rising gold prices and disciplined, self-funded growth initiatives. CGAU has delivered a 122.91% total return since April 2025, outperforming gold and the S&P 500, with robust free cash flow and minimal debt. Key projects—Mount Milligan, Kemess, Goldfield, and Thompson Creek—are fully funded from internal liquidity, supporting sustainable growth and shareholder returns.

ProShares UltraPro QQQ ETF provides a 3x leveraged approach to the Nasdaq-100 Index. While TQQQ may produce excess returns during bull markets, the results during declines can be disastrous for investors. It's important to understand the concept of volatility erosion, since TQQQ's returns may not always achieve its 3x daily goal.